PHASE II STUDY OF EVEROLIMUS AND CAPECITABINE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (HCC). RESULTS OF THE FIRST 10 PATIENTS INCLUDED